Working… Menu

Cabozantinib in Advanced Salivary Gland Cancer Patients (Cabo ASAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03729297
Recruitment Status : Terminated (safety issues)
First Posted : November 2, 2018
Last Update Posted : March 12, 2021
Information provided by (Responsible Party):
Radboud University

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 6, 2019
Actual Study Completion Date : November 6, 2019